Optimism and social support as contributing factors to spirituality in Cancer patients


Por: Ciria-Suarez, L, Calderon, C, Montes, A, Antonanzas, M, Hernandez, R, Rogado, J, Pacheo-Barcia, V, Ansensio-Martinez, E, Palacin-Lois, M and Jimenez-Fonseca, P

Publicada: 1 jun 2021 Ahead of Print: 1 ene 2021
Categoría: Oncology

Resumen:
Background/objective The impact a cancer diagnosis and its treatment are affected by psychosocial factors and how these factors interrelate among themselves. The objective of this study was to analyze the relationship between optimism and social support in spiritual wellbeing in cancer patients initiating chemotherapy. Methods A cross-sectional, multi-center (15 sites), prospective study was conducted with 912 cancer patients who had undergone curative surgery for a stage I-III cancer and were to receive adjuvant chemotherapy. They completed the Functional Assessment of Chronic Illness-Spiritual Well-being Scale (FACIT-Sp), Life Orientation Test-Revised (LOT-R), and the Multidimensional Scale of Perceived Social Support (MSPSS). Results Significant differences on spirituality scales (meaning/peace and faith) were detected depending on age (<= 65 vs > 65), sex, marital status, employment, and cancer treatment. Married or partnered participants had significantly higher meaning/peace scores compared to their non-partnered counterparts (p = 0.001). Women, > 65 years, unemployed, and patients treated with chemotherapy and radiotherapy had significantly higher faith scores versus men, <= 65 years, employed, and subjects only receiving adjuvant chemotherapy (all p < 0.030). Multivariate analyses indicated that meaning/peace and faith correlated positively with optimism and social support. Conclusion During oncological treatment, the positive effects of optimism and social support exhibit a positive correlation with spiritual coping. A brief assessment evaluation of these factors can aid in identifying at risk for a worse adaptation to the disease.

Filiaciones:
Ciria-Suarez, L:
 Univ Barcelona, Fac Psychol, Dept Clin Psychol & Psychobiol, Passeig Vall dHebron 171, Barcelona 08035, Spain

Calderon, C:
 Univ Barcelona, Fac Psychol, Dept Clin Psychol & Psychobiol, Passeig Vall dHebron 171, Barcelona 08035, Spain

Montes, A:
 Complejo Hosp Orense, Dept Med Oncol, Orense, Spain

 Hosp Univ Clin San Carlos, Dept Med Oncol, Madrid, Spain

Hernandez, R:
 Hosp Univ Marques Valdecilla, Dept Med Oncol, Santander, Spain

Rogado, J:
 Hosp Univ Infanta Leonor, Dept Med Oncol, Madrid, Spain

Pacheo-Barcia, V:
 Hosp Univ Cent Defensa Gomez Ulla, Dept Med Oncol, Madrid, Spain

:
 Hosp Univ Gen Elche, Dept Med Oncol, Alicante, Spain

Palacin-Lois, M:
 Univ Barcelona, Fac Psychol, Dept Social & Quantitat Psychol, Barcelona, Spain

Jimenez-Fonseca, P:
 Hosp Univ Cent Asturias, Dept Med Oncol, ISPA, Oviedo, Spain
ISSN: 14337339





SUPPORTIVE CARE IN CANCER
Editorial
Springer Verlag, 233 SPRING ST, NEW YORK, NY 10013 USA, Alemania
Tipo de documento: Article
Volumen: 29 Número: 6
Páginas: 3367-3373
WOS Id: 000604463800003
ID de PubMed: 33389086
imagen Green Accepted

MÉTRICAS